IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.18B | 1.14B | 1.10B | 1.06B | 1.03B |
| Total Depreciation and Amortization | 158.02M | 154.08M | 148.80M | 145.18M | 140.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.80M | 227.43M | 222.63M | 204.67M | 173.71M |
| Change in Net Operating Assets | -52.12M | -149.66M | -256.58M | -227.51M | -253.23M |
| Cash from Operations | 1.42B | 1.37B | 1.21B | 1.18B | 1.09B |
| Capital Expenditure | -114.99M | -117.18M | -126.63M | -124.68M | -124.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -223.43M | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.15M | -14.86M | -13.54M | -11.56M | -23.46M |
| Cash from Investing | -335.27M | -132.04M | -140.17M | -136.24M | -147.95M |
| Total Debt Issued | 269.00M | 190.00M | 460.50M | 398.00M | 205.00M |
| Total Debt Repaid | -400.00M | -325.00M | -428.39M | -428.39M | -103.39M |
| Issuance of Common Stock | 100.42M | 119.91M | 104.33M | 93.36M | 88.75M |
| Repurchase of Common Stock | -1.06B | -1.19B | -1.18B | -1.22B | -1.23B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.74M | -3.74M | -3.74M | -3.74M | -- |
| Cash from Financing | -1.09B | -1.21B | -1.05B | -1.16B | -1.04B |
| Foreign Exchange rate Adjustments | -1.08M | -1.50M | 12.71M | 11.20M | 1.46M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.63M | 32.34M | 36.56M | -108.20M | -100.47M |